Provisional biopharmaceutical classification of some common herbs used in western medicine

Molecular Pharmaceutics

Volumn 9, Issue 4, 2012, Pages 815-822

  Waldmann, Sarah ^a   Almukainzi, May ^a   Bou Chacra, Nadia Araci ^b   Amidon, Gordon L ^c   Lee, Beom Jin ^d,e   Feng, Jianfang ^f   Kanfer, Isadore ^g   Zuo, Joan Zhong ^h   Wei, Hai ^f   Bolger, Michael B ⁱ   Löbenberg, Raimar ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Kangwon National University   (South Korea)

^e Ajou University   (South Korea)

^f SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^g RHODES UNIVERSITY   (South Africa)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ Simulations Plus Inc   (United States)

Author keywords

Biopharmaceutical Classification System; dose number; herbal extracts; herbs; markers; permeability; solubility

Indexed keywords

ALLICIN; APIGENIN; CASCARA; CASCARA SAGRADA; CHAMOMILE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; QUERCETIN; RED CLOVER EXTRACT; SENNA EXTRACT; SILYBUM MARIANUM EXTRACT; VALERIAN;

ACTIVE TRANSPORT; ARTICLE; CLASSIFICATION; DRUG PENETRATION; DRUG SOLUBILITY; GARLIC; GINGER; GINKGO BILOBA; GINSENG; GLYCYRRHIZA; HERB; HYPERICUM PERFORATUM; MEDICAL LITERATURE; PH; PRIORITY JOURNAL; QUALITY CONTROL; RED CLOVER; SENNA; SILYBUM MARIANUM; VALERIANA;

BIOPHARMACEUTICS; PHARMACEUTICAL PREPARATIONS; PLANTS, MEDICINAL; SOLUBILITY;

EID: 84859329894     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200162b     Document Type: Article

References (36)

1. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 1995, 12 (3) 413-420
2. Löbenberg, R.; Amidon, G. L. Modern Bioavailability, Bioequivalence and Biopharmaceutical Classification System. New scientific approaches to international regulated standards Eur. J. Pharm. Biopharm. 2000, 50, 3-12 (Pubitemid 30326685)
3. World Health Organization, Geneva. Fortieth report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations; WHO Technical Report Series; World Health Organization: Geneva, 2006; No. 937, Annex 7.
4. Yu, L. X.; Amidon, G. L.; Polli, J. E.; Zhao, H.; Mehta, M. U.; Conner, D. P. Biopharmaceutics classification system: The scientific basis for biowaiver extensions Pharm. Res. 2002, 19 (7) 921-925 (Pubitemid 34804232)
5. Blume, H. H.; Schug, B. S. The biopharmaceutics classification system (BCS): Class III drugs - Better candidates for BA/BE waiver? Eur. J. Pharm. Sci. 1999, 9 (2) 117-121 (Pubitemid 30012067)
6. EMA-CHMP. Guideline on the Investigation of Bioequivalence. 2010.
7. European Medicines Agency. Herbal medicinal products. http://www.ema.europa.eu/ema/index.jsp?curl=/pages/home/Home-Page. jsp&jsenabled=true. Accessed Jan 6, 2011.
8. Health Canada, Natural Health Products Directorate. http://www.hc-sc.gc. ca/ahc-asc/branch-dirgen/hpfb-dgpsa/nhpd-dpsn/index-eng.php. Accessed Jan 6, 2011
9. Tong, C.; Lozano, R.; Mao, Y.; Mirza, T.; Ldbenberg, R.; Nickerson, B. The value of in Vitro dissolution in drug development: A position paper from the AAPS in Vitro release and dissolution focus group Pharm. Technol. 2009, 33 (4) 52-64
10. Lang, F.; Keller, K.; Ihrig, M.; Van Oudtshoorn-Eckard, J.; Möller, H.; Srinivasan, S. Biopharmaceutical characterization of herbal medicinal products Pharmacopeial Forum 2003, 29 (4) 1337-1345 (Pubitemid 44154475)
11. Lang, F.; Arzneimittel, W. S.; Keller, K.; Ihrig, M.; Van Oudtshoorn-Eckard, J.; Möller, H. Biopharmaceutical characterisation of herbal medicinal products: FIP-discussion paper. Part 1 Pharm. Ind. 2003, 65 (6) 547-550 (Pubitemid 36858069)
12. Wójcicki, J. Mater. Med. Pol. 1995, 27, 4) 141-146.
13. United States Pharmacopeia. USP Dietary Supplements Compendium; 2009-2010.
14. Drug information for Germany. Www.rote-liste.de
15. Fraczkiewicz, R. In silico prediction of ionization. In Comprehensive Medicinal Chemistry II; Testa, B.; van de Waterbeemd, H., Eds.; Elsevier: Oxford, U.K., 2006; Vol. 5, pp 603-26.
16. Mannhold, R.; Kubinyi, H.; Folkers, G. Drug Bioavailability, Estimation of Solubility, Permeability, Absorption and Bioavailability; Wiley VCH Verlag GmbH & Co, KgaA: Weinheim, 2009; Vol. 40, p 538.
17. FDA. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. 2000.
18. Wichtel, M. Teedrogen, 2 nd ed.; WVG: Stuttgart, 1989.
19. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-ginger-gingembre-eng. php.
20. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/archive-mono-ginko-biloba- eng.php.
21. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-garlic-ail-eng.php.
22. Canada, 18. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/ mono-cascara-eng.php.
23. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-senna-sene-eng.php.
24. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-thistle-chardon-eng. php.
25. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-ginseng-eng.php.
26. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/monolicorice-reglisse-eng. php.
27. Herbal Medicines. Available at: http://www.medicinescomplete.com/mc/ herbals/2008/1000736746.htm?q=%22red%20clover%22&t=search&ss=text&p= 1#hrb1000736758. Accessed Jan 6, 2011.
28. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-rom-chamom-eng.php.
29. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-stjohnswort- millepertuis-eng.php
30. Canada, Health. Natural Health Products Database. http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/mono-valerian-eng.php.
31. Hollman, P. C. H.; Bijsman, M. N. C. P.; Van Gameren, Y.; Cnossen, E. P. J.; De Vries, J. H. M.; Katan, M. B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man Free Radical Res. 1999, 31 (6) 569-573
32. Gee, J. M.; Dupont, M. S.; Rhodes, M. J. C.; Johnson, I. T. Quercetin glucosides interact with the intestinal glucose transport pathway Free Radical Biol. Med. 1998, 25 (1) 19-25 (Pubitemid 28285266)
33. Gugler, R.; Leschik, M.; Dengler, H. J. Disposition of quercetin in man after single oral and intravenous doses Eur. J. Clin. Pharmacol. 1975, 9 (2-3) 229-234
34. Graefe, E. U.; Wittig, J.; Mueller, S.; Riethling, A.; Uehleke, B.; Drewelow, B. Pharmacokinetics and bioavailability of quercetin glycosides in humans J. Clin. Pharmacol. 2001, 41 (5) 492-499 (Pubitemid 32381866)
35. Graefe, E. U.; Wittig, J.; Drewelow, B.; Riethling, A. K.; Mueller, S.; Wukasch, I.; Derendorf, H.; Veit, M. Relative systemic availability of the flavonoids quercetin and rutin in humans Pharm. Med. Chem. 1999, 332, 20
36. Takagi, T.; Ramachandran, C.; Bermejo, M.; Yamashita, S.; Yu, L. X.; Amidon, G. L. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan Mol. Pharmaceutics 2006, 3 (6) 631-643 (Pubitemid 46087480)